

Ependymitis granularis is purely an anatomical variant with no inflammatory etiology despite its name, contrary to a historical 1926 claim that linked it to chronic internal hydrocephalus.
Histologically, the lesions show focal ependymal breakdown, astrocytic gliosis, and decreased myelin with loose, random axonal organization that is smaller than adjacent normal white matter.
The increased periependymal and extracellular fluid contributes to the T2/FLAIR hyperintensity but does not represent true edema or pathology.
Recognition of the characteristic symmetrical, triangular, small morphology anterior and lateral to the frontal horns is essential to avoid misdiagnosis as demyelinating disease or ischemic change.
Clinical significance.
Usually incidental and asymptomatic: a normal correlate of aging and generalized cerebral atrophy in most cases.
Functional consequences when extensive: Because intact ependyma regulates fluid, ion, and small-molecule transport between parenchyma and CSF, widespread ependymal loss can impair this function and, with aqueductal involvement (e.g., mumps-related), cause acquired aqueductal stenosis and hydrocephalus.
Distinguish from true (infectious) ependymitis/ventriculitis, which is a clinically important, often severe process. Bacterial and fungal ependymitis are highly destructive, and infectious ventriculitis — associated with meningitis, ventricular catheters, or intraventricular abscess rupture — produces ependymal thickening, enhancement, and restricted-diffusion intraventricular debris on MRI, requiring CSF analysis and treatment. Granular ependymitis of aging is a separate, benign entity.
No clinical correlation or follow-up is needed when ependymitis granularis is confidently identified, as it is a benign incidental finding.
The distinction from pathologic lesions relies on size (>1 cm suggests pathology), asymmetry, and presence of T1 hypointensity in true lesions.